Cargando…
Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age
INTRODUCTION: Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as a preferred reliever. Many health systems and healthc...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882466/ https://www.ncbi.nlm.nih.gov/pubmed/33586006 http://dx.doi.org/10.1007/s12325-021-01621-0 |